CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 67,700 shares, an increase of 145.3% from the March 31st total of 27,600 shares. Based on an average daily trading volume, of 530,200 shares, the days-to-cover ratio is currently 0.1 days.

CV Sciences Price Performance

CV Sciences stock opened at $0.04 on Friday. CV Sciences has a 52 week low of $0.03 and a 52 week high of $0.06. The business has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.04. The stock has a market cap of $6.15 million, a price-to-earnings ratio of 1.89 and a beta of 0.62.

CV Sciences (OTCMKTS:CVSI) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. CV Sciences had a return on equity of 80.98% and a net margin of 19.38%. The firm had revenue of $3.80 million for the quarter.

About CV Sciences

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.